TPST

Tempest Therapeutics, Inc.$1.28+0.03 (+2.40%)

Prev Close$1.25·MCap$10.6M·P/E—·Vol34.3K·Yield—

▲

Buys (12M)

$500.0K

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$500.0K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Tempest Therapeutics, Inc. (TPST) has been exclusively buying, with 1 insider purchase totaling $500.0K and 0 insider sales totaling $0.00. The most recent insider transaction was by Angel Matthew (director, 10 percent owner, officer: CEO and President), who purchased $500.0K worth of shares on Mar 25, 2026. Tempest Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $10.6M.

TPST Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 25, 2026	Angel Matthew	director, 10 percent owner, officer: CEO and President	Buy	231,482	$2.16	$500.0K5.2% OS	231,482
Aug 12, 2024	Versant Venture Capital VI, L.P.		Sell	787,999	$1.23	$967.0K17.7% OS	597,940-57%
Jul 8, 2024	Brady Stephen R	President and CEO	Buy	35,000	$2.11	$73.8K0.8% OS	46,376+308%
Jul 3, 2024	Whiting Samuel	Chief Medical Officer	Buy	4,672	$2.13	$10.0K	9,573+95%
Jul 2, 2024	Trojanowski Justin	Corporate Controller	Buy	7,500	$2.16	$16.2K	22,168+51%
May 3, 2022	Woiwode Thomas	Director	Buy	2,118,644	$2.36	$5.00M47.7% OS	2,118,644
Jan 11, 2022	Dubensky Thomas W.	President	Buy	2,000	$4.78	$9.6K	113,343
Jan 10, 2022	Whiting Samuel	Chief Medical Officer	Buy	1,700	$4.80	$8.2K	1,901+846%

TPST Insider Buying Activity

The following table shows recent insider purchases of Tempest Therapeutics, Inc. (TPST) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 25, 2026	Angel Matthew	director, 10 percent owner, officer: CEO and President	Buy	231,482	$2.16	$500.0K5.2% OS	231,482
Jul 8, 2024	Brady Stephen R	President and CEO	Buy	35,000	$2.11	$73.8K0.8% OS	46,376+308%
Jul 3, 2024	Whiting Samuel	Chief Medical Officer	Buy	4,672	$2.13	$10.0K	9,573+95%
Jul 2, 2024	Trojanowski Justin	Corporate Controller	Buy	7,500	$2.16	$16.2K	22,168+51%
May 3, 2022	Woiwode Thomas	Director	Buy	2,118,644	$2.36	$5.00M47.7% OS	2,118,644
Jan 11, 2022	Dubensky Thomas W.	President	Buy	2,000	$4.78	$9.6K	113,343
Jan 10, 2022	Whiting Samuel	Chief Medical Officer	Buy	1,700	$4.80	$8.2K	1,901+846%